Correction: The deubiquitylase USP9X controls ribosomal stalling
Anne Clancy(University of Liverpool), Michael J. Clague(University of Liverpool), Simon Davis, Benedikt M. Kessler(University of Oxford), Victoria Smith(Rockefeller University Press), Sylvie Urbé(University of Liverpool), Adán Pinto-Fernández(Discovery Centre), Marie Katz(Rockefeller University Press), Katherine J. Kayser-Bricker(Forma Therapeutics (United States)), Andreas Kallinos(Rockefeller University Press), Tim Hammonds, Crystal McKinnon(Rockefeller University Press), Stephanos Ioannidis(Forma Therapeutics (United States)), Axel Behrens(King's College London), Jonathan C. O’Connell, Claire Heride(Rockefeller University Press), Steven Mischke(Rockefeller University Press), Bruce Follows(Rockefeller University Press), Shawn P. Fessler(Rockefeller University Press), Justin A. Caravella(Rockefeller University Press), David Komander(Walter and Eliza Hall Institute of Medical Research), Weiping Wang(Zhejiang Sci-Tech University), Neil P. Jones(Rockefeller University Press), Sunkyu Kim(Korea University), Christopher J. Dinsmore(United States Military Academy), Hannah Elcocks(University of Liverpool)
Cited by 6
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Structural insights into the catalytic mechanism of a family 18 exo-chitinase
|Proceedings of the National Academy of Sciences|2001|462